Drug–Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study

This Italian observational real-world study aims to assess in chronic hepatitis C virus (HCV) patients treated with pangenotypic direct acting agents (pDAAs) glecaprevir/pibrentasvir (GLE/PIB) or sofosbuvir/velpatasvir (SOF/VEL) the potential drug–drug interactions (DDIs) with concomitant medication...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangia, Alessandra, Scaglione, Francesco, Toniutto, Pierluigi, Pirisi, Mario, Coppola, Nicola, Di Perri, Giovanni, Alvarez Nieto, Gema, Calabrese, Stefano, Hernandez, Candido, Perrone, Valentina, Degli Esposti, Luca, Fagiuoli, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296917/
https://www.ncbi.nlm.nih.gov/pubmed/34281080
http://dx.doi.org/10.3390/ijerph18137144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296917/
https://www.ncbi.nlm.nih.gov/pubmed/34281080
http://dx.doi.org/10.3390/ijerph18137144

Ejemplares similares